A Randomised, Multi-Centre, Phase IV, Double-Blind, Parallel Group Study Comparing the Effects of 52 Weeks Administration of AVANDAMET and Metformin Plus Sulphonylurea on Change in HbA1c From Baseline in Overweight Type 2 Diabetics Poorly Controlled on Metformin.
A Randomised, Multi-Centre, Phase IV, Double-Blind, Parallel Group Study Comparing the Effects of 52 Weeks Administration of AVANDAMET and Metformin Plus Sulphonylurea on Change in HbA1c From Baseline in Overweight Type 2 Diabetics Poorly Controlled on Metformin.
This study compares the effects of Avandamet (rosiglitazone maleate/metformin) treatment and metformin plus sulphonylurea treatment in overweight people with type 2 diabetes.
Inclusion criteria:
Exclusion criteria:
Bergkamen-Rünthe, North Rhine-Westphalia 59192, Germany
Alcobendas/Madrid, 28100, Spain
Alcora/Castellón, 12110, Spain
Artana/Castellón, 12527, Spain
Móstoles/Madrid, 28935, Spain
Santa Coloma de Gramanet (Barcelona), 08923, Spain